Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Performance of 18F-FDG PET/MR on TNM staging of pancreatic cancer compared with 18F-FDG PET/CT: A retrospective cohort study (2024) |
Titre original: | Performance du 18F-FDG TEP/IRM sur la stadification TNM du cancer du pancréas en comparaison avec le 18F-FDG TEP/TDM : une étude rétrospective dune cohorte |
Auteurs : | S. Liu, Auteur ; B. Li, Auteur ; J. Hao, Auteur ; Z. Zhang, Auteur ; H. Shi, Auteur |
Type de document : | Article |
Dans : | Médecine nucléaire (Vol 48, n°1, février 2024) |
Article en page(s) : | 8-15 |
Note générale : | Doi : 10.1016/j.mednuc.2023.06.003 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Stadification tumorale ; TEP/TDMAutres descripteurs TEP IRM |
Mots-clés: | Cancer du pancréas ; FDG |
Résumé : |
Purpose
This study aimed to evaluate the TNM staging accuracy of 18F-FDG PET/MR compared with 18F-FDG PET/CT in patients with pancreatic cancer. Materials and methods In this retrospective cohort study, a total of 88 patients (53 men, 35 women, mean age 64.56±10.77 years) with pathologically confirmed pancreatic cancer who underwent 18F-FDG PET/CT and 18F-FDG PET/MR successively on the same day were enrolled. The maximal and peak standardized uptake values (SUVmax and SUVpeak ) of pancreatic cancer lesions on PET/MR and PET/CT imaging were measured respectively. According to the 8th edition AJCC staging system of pancreatic adenocarcinoma, two experienced readers reviewed and assessed the PET/CT and PET/MR images independently for TNM staging. Using the diagnosis of enhanced CT, histopathological diagnosis and/or the clinical follow-up as the reference, the diagnostic performance of PET/CT and PET/MR were compared using the McNemar test. Results Compared with 18F-FDG PET/CT (63.64%), 18F-FDG PET/MR (85.23%) exhibited significantly higher diagnostic accuracy of T staging (P Conclusions Compared with 18FFDG PET/CT, 18FFDG PET/MR showed better performance in the TNM staging of pancreatic cancer, especially in T staging and detection of liver metastases. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.em-premium.com/article/1647775 |